BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mizokami Y. Efficacy and safety of rabeprazole in non-steroidal anti-inflammatory drug-induced ulcer in Japan. World J Gastroenterol 2009; 15(40): 5097-5102 [PMID: 19860005 DOI: 10.3748/wjg.15.5097]
URL: https://www.wjgnet.com/1007-9327/full/v15/i40/5097.htm
Number Citing Articles
1
Ai Fujimoto, Toshio Uraoka, Toshihiro Nishizawa, Masayuki Shimoda, Osamu Goto, Yasutoshi Ochiai, Tadateru Maehata, Teppei Akimoto, Yutaka Mitsunaga, Motoki Sasaki, Hiroyuki Yamamoto, Naohisa Yahagi. Rebamipide solution: a novel submucosal injection material to promote healing speed and healing quality of ulcers induced by endoscopic submucosal dissectionGastrointestinal Endoscopy 2018; 87(4): 1114 doi: 10.1016/j.gie.2017.09.040
2
Motoyasu Kusano, Shikou Kuribayashi, Osamu Kawamura, Yasuyuki Shimoyama, Hiroko Hosaka, Atsuto Nagoshi, Hiroaki Zai, Masatomo Mori. A Review of the Management of Gastric Acid-Related Diseases: Focus on RabeprazoleClinical Medicine. Gastroenterology 2011; 4: CGast.S5133 doi: 10.4137/CGast.S5133
3
Hailing Ma, Xin Zhang, Feifei Ju, Sang-Bing Tsai. A Study on Curing Kinetics of Nano-Phase Modified Epoxy ResinScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-21208-0
4
Ema Washio, Motohiro Esaki, Yuji Maehata, Masashi Miyazaki, Hiroyuki Kobayashi, Hideki Ishikawa, Takanari Kitazono, Takayuki Matsumoto. Proton Pump Inhibitors Increase Incidence of Nonsteroidal Anti-Inflammatory Drug–Induced Small Bowel Injury: A Randomized, Placebo-Controlled TrialClinical Gastroenterology and Hepatology 2016; 14(6): 809 doi: 10.1016/j.cgh.2015.10.022
5
RabeprazoleReactions Weekly 2021; 1853(1): 415 doi: 10.1007/s40278-021-95281-y
6
Current awareness: Pharmacoepidemiology and drug safetyPharmacoepidemiology and Drug Safety 2010; 19(5) doi: 10.1002/pds.1850